While these factors limit our ability to perform a number of additional informative analyses (e.g., tumor/relapse paired CTNNB1 immunohistochemistry), it is extremely important to consider that patients with relapsed SCLC rarely undergo biopsies that yield enough tissue for high throughput sequencing. This evidence concerns the gene CTNNB1 and small cell lung carcinoma.